PIDOTIMOD IN TREATMENT OF ACUTE RESPIRATORY INFECTION IN FREQUENTLY AILING CHILDREN

F.S. Kharlamova; V.F. Uchaikin; O.V. Kladova; S.L. Bevza

PIDOTIMOD IN TREATMENT OF ACUTE RESPIRATORY INFECTION IN FREQUENTLY AILING CHILDREN

F.S. Kharlamova, V.F. Uchaikin, O.V. Kladova, S.L. Bevza

Abstract

This trial studied effectiveness and safety of pidotimoid (Imunorix) in complex treatment of children with acute respiratory infection (ARI). Treatment with pidotimoid during 2 weeks (n = 30) resulted in lesser duration of fever and intoxication symptoms, and symptoms of laryngo-tracheitis, compared to control group (n = 30). Besides, children from pidotimoid group showed more rapid transformation of dry cough to hydrated cough, and decrease of its intensity. This beneficial change was accompanied by improvement of microbiocenosis. Effectiveness of pidotimoid was estimated by 73% of doctors as «good» (67% in control group). There was no any complication, related to treatment with this medication. The rate of repeated cases of ARI was three times lower then in control group in 6 months. All patients with ARI had no recurrent laryngeal stenosis.
Key words: frequently ailing children, acute respiratory infection, treatment, prophylaxis, pidotimoid.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(2):27-33)

About the Authors

F.S. Kharlamova

Russian State Medical University, Moscow
Russian Federation

V.F. Uchaikin

Russian State Medical University, Moscow
Russian Federation

O.V. Kladova

Russian State Medical University, Moscow
Russian Federation

S.L. Bevza

Russian State Medical University, Moscow
Russian Federation

References

1. Острые респираторные заболевания у детей: лечение и профилактика. Научно–практическая программа Союза педиатров России. 2002. 73 с.

2. Альбицкий В.Ю., Баранов А.А. Часто болеющие дети. Клинико–социальные аспекты. Пути оздоровления. Саратов. 1986. 45 с.

3. Кладова О.В., Харламова Ф.С., Легкова Т.П. и др. Клинико-патогенетическое обоснование применения ИРС 19 у детей с бронхолегочными заболеваниями. Вопросы современной педиатрии. 2002; 1 (3): 36–39.

4. Careddu P., Mei V., Venturoli V., Corsini A. Pidotimod in the treatment of recurrent respiratory infections in paediatric patients. Arzneimittelforschung. 1994; 44 (12): 1485–1489.

5. Illeni M.T., Bombelli G., Poli A., Pattarino P.L. NK cell cytotoxic activity induced by a synthetic immunostimulant (pidotimod): an in vitro study. J. Chemother. 1991; 3 (Supрl. 3):157–159.

6. Сенцова Т.Б., Ревякина В.А. Современные иммуномодуляторы в практике педиатра. М.: Materia medica. 2006. С. 41–43.

7. Burgio G.R., Marseglia G.L., Severi F. et al. Immunoactivation by pidotimod in children with recurrent respiratory infections. Arzneimittelforschung. 1994; 44 (12): 1525–1529.

8. Pugliese A. et al. Evaluation of the effect of pidotimod on the in vitro production of interferons. Int. J. Immunotherapy. 1995; 11: 71–76.

9. Pugliese A. et al. Evaluation of the effect of pidotimod on the immune system. Int. J. Immunotherapy. 1992; 3: 212–219.

10. Caramia G., Clemente E., Solli R. et al. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children. Arzneimittelforschung. 1994; 44 (12): 1480–1484.

11. De Martino P. and the multicentre study group. Pidotimod: efficacy and tolerability profile in the prophylaxis of RRI. 3rd International Conference on Pediatric Otorhinolaryngology. 1993 (Abstracts).

Review

For citations:

Kharlamova F., Uchaikin V., Kladova O., Bevza S. PIDOTIMOD IN TREATMENT OF ACUTE RESPIRATORY INFECTION IN FREQUENTLY AILING CHILDREN. Current Pediatrics. 2009;8(2):27-33.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Current Pediatrics

PIDOTIMOD IN TREATMENT OF ACUTE RESPIRATORY INFECTION IN FREQUENTLY AILING CHILDREN

Abstract

About the Authors

References

Review

For citations:

Cookies policy